Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

biote Corp. Director's Dealing 2022

May 31, 2022

33946_dirs_2022-05-31_b5767806-fa5c-4442-ab1e-ee1504bfced9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: biote Corp. (BTMD)
CIK: 0001819253
Period of Report: 2022-05-26

Reporting Person: Gibbins Robbin Charles (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-05-26 Phantom Stock $ A 295000 Acquired 2023-07-01 Class A Common Stock (295000) Direct

Footnotes

F1: Each share of phantom stock is the economic equivalent of one share of Issuer Class A Common Stock.

F2: Received pursuant to the Business Combination Agreement between Haymaker Acquisition Corp. III, a Delaware corporation, Haymaker
Sponsor III LLC, a Delaware limited liability company, BioTE Holdings, LLC, a Nevada limited liability company ("Biote"), BioTE Management,
LLC, a Nevada limited liability company, Dr. Gary Donovitz, in his individual capacity and Teresa S. Weber, in her capacity as the members'
representative.

F3: The phantom stock shall vest on 1/4th on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023.